Abstract
Genotyping of Mycoplasma pneumoniae, a pathogen responsible for community-acquired pneumonia that occurs both endemically and epidemically worldwide, is essential for understanding M. pneumoniae distribution and relatedness and for determining the epidemiology of infection caused by this pathogen. It may also explain most phenotypic variability, such as geographic distribution, host specificity, antibiotic resistance, and virulence. However, the molecular typing is hampered by the fact that M. pneumoniae is a genetically homogeneous species in which large genomic rearrangements do not frequently occur. For these reasons, it has been difficult to develop a typing method with a good discriminatory power below the species level. Many molecular methods have been used for genotyping M. pneumoniae. Some of them are based on studying the banding pattern profiles resulting from endonuclease restriction, or from PCR amplification combined with or without restriction, while some others study DNA sequence polymorphisms by sequencing. According to the method used, the target can be a single gene, multiple genes, or the whole genome. In this review, we describe these methods following the classification mentioned above. We also discuss the epidemiological value of M. pneumoniae genotyping particularly for the most commonly used techniques.
Keywords: Epidemiology, genotyping, Mycoplasma pneumoniae, outbreak, typing method.
Current Pediatric Reviews
Title:Strain Typing of Mycoplasma pneumoniae and its Value in Epidemiology
Volume: 9 Issue: 4
Author(s): Arabella Touati, Charles Cazanave and Cécile Bébéar
Affiliation:
Keywords: Epidemiology, genotyping, Mycoplasma pneumoniae, outbreak, typing method.
Abstract: Genotyping of Mycoplasma pneumoniae, a pathogen responsible for community-acquired pneumonia that occurs both endemically and epidemically worldwide, is essential for understanding M. pneumoniae distribution and relatedness and for determining the epidemiology of infection caused by this pathogen. It may also explain most phenotypic variability, such as geographic distribution, host specificity, antibiotic resistance, and virulence. However, the molecular typing is hampered by the fact that M. pneumoniae is a genetically homogeneous species in which large genomic rearrangements do not frequently occur. For these reasons, it has been difficult to develop a typing method with a good discriminatory power below the species level. Many molecular methods have been used for genotyping M. pneumoniae. Some of them are based on studying the banding pattern profiles resulting from endonuclease restriction, or from PCR amplification combined with or without restriction, while some others study DNA sequence polymorphisms by sequencing. According to the method used, the target can be a single gene, multiple genes, or the whole genome. In this review, we describe these methods following the classification mentioned above. We also discuss the epidemiological value of M. pneumoniae genotyping particularly for the most commonly used techniques.
Export Options
About this article
Cite this article as:
Touati Arabella, Cazanave Charles and Bébéar Cécile, Strain Typing of Mycoplasma pneumoniae and its Value in Epidemiology, Current Pediatric Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/157339630904131223111632
DOI https://dx.doi.org/10.2174/157339630904131223111632 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
Call for Papers in Thematic Issues
Early-life nutrition: impacts on health and diseases
In early life, organs and hormonal axes are especially susceptible to changes that can affect the intestinal mucosa, immune system, and long-term health. Critical factors in the developmental process, including maternal diet, type of delivery, breastfeeding, and the nutritional status of mothers and children, have gained prominence. Evidence suggests that ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetics, Pharmacodynamics and Clinical Use of Valganciclovir in Newborns with Symptomatic Congenital Cytomegalovirus Infection
Current Drug Metabolism Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis
Current HIV Research Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy
Current Gene Therapy Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry Sex Steroids in Autoimmune Diseases
Current Topics in Medicinal Chemistry Unexpected Altered Specificity Is Responsible for St. Louis Encephalitis Virus Recombinant Protease Autoproteolysis
Protein & Peptide Letters The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?
Current Gene Therapy COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses Delivery of Anti-Viral Nucleoside Analogues to the Central Nervous System
Current Medicinal Chemistry - Anti-Infective Agents In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Current Medicinal Chemistry - Central Nervous System Agents Engineering of Chimeric Protein Based on E Protein Domain III of Tick- Borne Encephalitis Virus and OmpF Porin of Yersinia pseudotuberculosis
Protein & Peptide Letters Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Current Neuropharmacology Host-Pathogen Interactions in Latent Mycobacterium tuberculosis Infection: Identification of New Targets for Tuberculosis Intervention
Endocrine, Metabolic & Immune Disorders - Drug Targets Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Mortality from Herpes Simplex Virus (HSV) Infection in Australian Children, 1999-2011 Using National Datasets
Infectious Disorders - Drug Targets Microneedle Patches as Drug and Vaccine Delivery Platform
Current Medicinal Chemistry Dementia Etiologies and Remedies in Traditional Persian Medicine; A Review of Medicinal Plants and Phytochemistry
Current Drug Metabolism Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle
CNS & Neurological Disorders - Drug Targets